• Side Effects Include Disruption

  • Guest list


      Anne Wojcicki

      Is an entrepreneur and co-founder and CEO of 23andMe.


      Dr. Jeffrey Trent

      Is the president and research director of the Translational Genomics Research Institute, or TGEN, in Phoenix, Arizona, an affiliate of the City of Hope.  


      Dr. Giselle Sholler

      Is the director of the Haworth Innovative Therapeutics Clinic at Helen DeVos Children's Hospital. She’s also the director of the pediatric oncology research program there, and the chair of the Beat Childhood Cancer Consortium.  


      Dr. Daniel Kraft

      Is a physician-scientist. He chairs the Medicine and Neuroscience Track for Singularity University and he’s also the founder and chair of Exponential Medicine, a program where we look at the future of healthcare through the lens of accelerating technologies.


      Reenita Das

      Is a partner and senior vice-president at Frost and Sullivan. She’s been in the healthcare business for the past 25 years, and helps companies globally explore growth opportunities and how to grow their business in this dynamic world.

  • You may also be interested in

      Data offers new hope to transforming health

      Watch how Partners HealthCare provides researchers and clinicians with a data lake and analytical tools to conduct sophisticated research, develop new insights, and advance health care innovation.


      Advancing the diagnosis and treatment of pediatric cancer

      Watch how Dell is teaming up with TGEN to help researchers deliver more precise treatment plans, quicker, for pediatric cancer cases.


      Realizing 2030: The Human Machine Partnership

      Our relationship with machines and technology has shaped our modern existence. With 2030 in our sights, realize the true potential of our relationship with technology to drive human progress.